Greenlight Capital — Unmapped CUSIP

How Greenlight Capital's position in Gain Therapeutics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing. CUSIP 36269B105 needs mapping

Quarters held

2

First reported

Q1 2026

Latest value

$1,149,244

Latest weight

0%

Peak weight

0%

Shares since first

0%

Position Trend

Shares, value, and weight from first report to latest report.

Greenlight Capital first reported 566,130 shares in Q1 2026 and most recently reported 566,130 shares in Q2 2026. Portfolio weight peaked at 0% in Q2 2026; the low reported weight was 0% in Q2 2026.

Since the first report, shares are 0% and reported value is +4.6%. Latest move: —